Forskargatan 20 G
Södertälje 151 36
Sweden
46 8 41 07 49 49
https://www.nanologica.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 16
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Andreas Bhagwani | Chief Executive Officer | 2,82M | N/A | 1975 |
Ms. Eva Osterman | Chief Financial Officer | N/A | N/A | 1971 |
Ms. Åsa Bergström | Chief Operating Officer | N/A | N/A | 1964 |
Johanna Johansson | Director of IR, Communications & Marketing | N/A | N/A | N/A |
Dr. P. K. Dutta | Senior VP of Sales & Senior Advisor of Chromatography | N/A | N/A | N/A |
Ms. Katarina Alenas | Senior Vice President of Chromatography | N/A | N/A | 1970 |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns. The company provides products for the analysis and purification of substances, with a focus on peptides and diabetes drugs. In addition, it is involved in the development of nanoporous amorphous particles (NAP), a platform technology for inhalation to give access to new or enhanced treatments for the patients with severe lung diseases. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
El ISS Governance QualityScore de Nanologica AB (publ), a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.